GlassScriptPhysician profile
Chun-Yu Lee
NPI 1972860104
$2,167.95
in general payments reported to CMS, 2019-2025
21 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $677 · 2021: $657 · 2022: $210 · 2024: $44.71 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $525.07 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.60 | 2019-2021 | |
| Amgen INC. | $261.16 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.90 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $157.86 | 2021 | |
| Chiesi USA, INC. | $94.81 | 2020-2021 | |
| Pfizer INC. | $92.73 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $82.87 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $68.51 | 2019-2020 | |
| Philips North America LLC | $61.87 | 2024-2025 | (6585) Omniwire, (9266) Elca, Coronary Other |
| Amarin Pharma, INC. | $60.71 | 2019-2020 | |
| Medtronic, INC. | $38.10 | 2025 | Symplicity G3 |
| Stryker Corporation | $34.32 | 2025 | Clottriever Bold Catheter, Flowtriever, Artix Mt |
| Sanofi-Aventis U.S. LLC | $30.81 | 2020 | |
| Teleflex LLC | $28.78 | 2025 | Guideliner |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $26.51 | 2021 | |
| Lundbeck LLC | $21.79 | 2019 | |
| Bardy Diagnostics, INC. | $20.97 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.01 | 2020 | |
| Irhythm Technologies, INC. | $17.83 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $15.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chun-Yu Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.